This story has been updated with additional details from UnitedHealthcare's coverage policy.
NEW YORK – UnitedHealthcare has issued a positive coverage decision for Myriad Genetics' GeneSight Psychotropic pharmacogenetic test, Myriad disclosed in a filing with the US Securities and Exchange Commission today.